Markets Leede Financial starts Nanalysis Scientific at buy; PT C$0.90 Leede Financial launched coverage of Nanalysis Scientific (TSXV: NSCI) (OTCQX: NSCIF) with a “speculative buy” rating and C$0.90 target price. The stock closed at $0.365 on November 22. Nanalysis operates two distinct... November 25, 2024